Taysha Gene Therapies TSHA Earnings Call Transcripts

NASDAQ TSHA
$4.28 -0.09 (-2.17%)
At close: Nov 10, 2026 · 4:00 PM EST
10 earnings calls on file for Taysha Gene Therapies, from Q4 2020 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Taysha Gene Therapies Q2 2026 Earnings Call

Aug 11, 2026 7,717 words · 34 min read
  • Hayleigh CollinsVice President of Corporate Communications and Investor Relations
  • Sean NolanChief Executive Officer
  • Sukumar NagendranPresident and Head of R&D
  • Kamran AlamChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Taysha Gene Therapies Earnings Call Transcripts

Calls10
LatestAug 11, 2026
SinceQ4 2020

Fiscal 2026

Fiscal 2025

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 10 Taysha Gene Therapies transcripts Register to get access to Taysha Gene Therapies’s earnings call transcripts.